Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.00
Bid: 1,772.50
Ask: 1,773.50
Change: 12.00 (0.68%)
Spread: 1.00 (0.056%)
Open: 1,770.00
High: 1,774.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Energy, healthcare stocks lift FTSE 100; BHP Group shines

Tue, 17th Aug 2021 09:46

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* UK employment closer to pre-pandemic levels

* BHP Group jumps on strong results

* PLUS500 gains on robust revenue forecasts

* FTSE 100 up 0.3%, FTSE 250 off 0.2%
(Updates to close)

By Shashank Nayar and Amal S

Aug 17 (Reuters) - London's FTSE 100 rose on Tuesday, helped
by gains in heavyweight energy and healthcare stocks, with
sentiment bolstered by robust earnings from BHP Group and
employment numbers that showed a steady economic recovery in the
UK.

After falling as much as 0.5%, the blue-chip FTSE 100 index
ended 0.3% higher, helped by oil majors BP and
Royal Dutch Shell as crude prices recouped early
losses.

Healthcare stocks rose 1.1% with drugmakers
including AstraZeneca, GlaxoSmithKline, and
Hikma Pharmaceuticals rising between 1% and 2.3%.

Miner BHP Group gained 3.1% to the top of the FTSE
100 after posting its best annual profit in nearly a decade. It
also announced an exit from its $13 billion petroleum business
in a portfolio shake-up that will see it leave London's FTSE 100
index.

"BHP has a clear strategy now of focusing on future-proofed
commodities which are part of the transition away from fossil
fuels or in other words being part of the solution rather than
part of the problem and it's an approach which is winning favour
from the market," said Russ Mould, investment director at AJ
Bell.

Steadily rising commodity prices and cheap interest rates
have helped the FTSE 100 rise nearly 11% year-to-date, but
inflation pressure, risks linked to the coronavirus pandemic and
less weightage of tech stocks on the index have led it to
underperform developed-market peers.

The number of employees on British company payrolls rose by
182,000 in July from June, moving closer to their pre-pandemic
level as the economy recovers from its coronavirus lockdowns,
tax data showed.

Unemployment in the UK dropped to 4.7% in the three months
to June, lower than economist expectations of 4.8%.

The domestically focussed mid-cap index eased 0.2%,
with travel stocks declining the most.

Online trading platform Plus500 jumped 5.1% to the
top of the mid-cap index after it forecast annual revenue
"significantly ahead" of analysts' estimates.

UK-listed shares of food-ordering firm Just Eat Takeaway.com
gained 2.9% and was the second-best performer on FTSE
100, after it reported a better-than-expected operating loss of
190 million euros ($224 million) for the first half of
2021.
(Reporting by Shashank Nayar and Amal S in Bengaluru; Editing
by Subhranshu Sahu and Uttaresh.V and Bernadette Baum)

More News
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.